News
Since June, the group has blown up in America with an album at No. 3 on Billboard and a hit single climbing up the Hot 100.
While the total number of drug shortages in the U.S. appears to be decreasing in 2025, some shortages of essential medications have yet to be resolved. Erin Fox, PharmD, senior pharmacy director at ...
The main patent for Ohtuvayre, the COPD drug at the heart of Verona’s $10 billion sale, expired in 2020. For Merck to make ...
From Monopoly Go’s 90s sitcom parody to Greenpeace’s outdoor protest and Hiscox’s ruined direct mail, this week’s best ads ...
A steady stream of visitors to the stand throughout the day took advantage of the nurse-led checks including blood pressure, ...
1h
The Business & Financial Times on MSNFrom product to brand: Why SMEs should invest in brandingIn today’s highly competitive business environment, it is no longer sufficient for firms (particularly small and medium-sized enterprises) to merely offer a product.The ability to build and maintain a ...
1h
Zacks Investment Research on MSNABBV or BMY: Which Biopharma Giant Has Better Prospects for Now?AbbVie, Inc. ABBV and Bristol Myers Squibb BMY are leading drugmakers with broad and diverse portfolios and a global footprint. AbbVie is a global, diversified biopharmaceutical company with a ...
A new security screener that people can simply walk past may soon be coming to an airport near you. Last year, U.S. airports ...
Indian drug firm Wockhardt announces exit from its loss-incurring US generic business to concentrate on innovative ...
Wockhardt will exit its loss-making US generic business to focus on antibiotics and diabetes care. The company filed for ...
Wockhardt says its US generics business has been loss-making for several years, incurring a loss of nearly $8 million in FY25 ...
Trying to quickly turn a browser extension into a new revenue stream can backfire—common missteps can damage trust and tank ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results